Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mitozantrone (Pfizer (Perth)) 10 mg/5 mL injection, 5 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 10 mg/5 mL injection, 5 mL vial |
Is a |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 10 mg/5 mL injection, 5 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 30 mg/15 mL injection, 15 mL vial |
Is a |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 30 mg/15 mL injection, 15 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 25 mg/12.5 mL injection, 12.5 mL vial |
Is a |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 25 mg/12.5 mL injection, 12.5 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 20 mg/10 mL injection, 10 mL vial |
Is a |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 20 mg/10 mL injection, 10 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 30 mg/15 mL injection, 15 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 25 mg/12.5 mL injection, 12.5 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|
Mitozantrone (Pfizer (Perth)) 20 mg/10 mL injection, 10 mL vial |
has TP |
True |
Mitozantrone (Pfizer (Perth)) |
Inferred relationship |
Some |
|